Table 2.
Complete Blood Count with Differential of CD-1 Mice after Exposure to FK20 and FdKa
| analytes | saline | FK20 | FdK | reference range |
|---|---|---|---|---|
| red blood cells (×106/μL) | 9.10 ± 0.57 | 8.85 ± 0.28 | 9.04 ± 0.16 | 8.49–10.43 |
| hemoglobin (g/dL) | 14.52 ± 0.57 | 14.16 ± 0.59 | 14.22 ± 0.13 | 13.8–16.8 |
| hematocrit % | 42.96a ± 1.22 | 40.72b ± 1.11 | 41.38ab ± 0.23 | 47.0–39.3 |
| mean cell volume (fL) | 47.30 ± 1.94 | 46.00 ± 1.3 | 45.76 ± 0.69 | 42.3–48.0 |
| MCH (pg) | 15.98 ± 0.64 | 15.98 ± 0.85 | 15.72 ± 0.38 | 14.7–17.5 |
| MCHC (g/dL) | 33.78 ± 0.4 | 34.76 ± 0.92 | 34.36 ± 0.29 | 34.1–36.7 |
| platelet estimate (×103/μL) | 232.40 ± 220.15 | 256.00 ± 55.71 | 144.00 ± 66.75 | 784–1812 |
| WBC count (×103/μL) | 6.31a ± 1.19 | 8.29b ± 0.86 | 7.89ab ± 1.29 | 7.06–17.29 |
| Neu % | 17.30 ± 8.86 | 16.56 ± 8.13 | 18.86 ± 10.61 | 8.74–55.68 |
| Lymph % | 80.12 ± 9.73 | 72.32 ± 10.37 | 75.30 ± 11.83 | 37.50–85.01 |
| Mono % | 1.06a ± 0.13 | 2.82b ± 1.29 | 1.64ab ± 1.13 | 2.84–13.09 |
| Eos % | 1.44 ± 1.1 | 7.08 ± 5.31 | 4.12 ± 1.43 | 0.30–5.20 |
| Baso % | 0.08 ± 0.13 | 0.02 ± 0.04 | 0.08 ± 0.11 | 0.00–0.17 |
| A Neu (×103/μL) | 1.13 ± 0.7 | 1.39 ± 0.74 | 1.41 ± 0.55 | 0.98–6.06 |
| A Lymph (×103/μL) | 5.01 ± 0.89 | 5.97 ± 0.92 | 6.02 ± 1.59 | 5.01–11.60 |
| A Mono (×103/μL) | 0.07a ± 0.02 | 0.24b ± 0.13 | 0.14ab ± 0.1 | 0.09–0.63 |
| A Eos (×103/μL) | 0.10a ± 0.08 | 0.69b ± 0.33 | 0.31a ± 0.07 | 0–0.75 |
| A Baso (×103/μL) | 0.01 ± 0.01 | 0.00 ± 0 | 0.01 ± 0.01 | 0–0.09 |
a
Letters a and b online in rows are to denote statistical significance: mean values with at least one letter in common are not significantly different. If no letters are present in a row, none of the mean values in that row are significantly different. Significance was determined in R with ANOVA and Tukey mean separation; p < 0.05 for significance.